OCULAR THERAPEUTIX, INC short interest in 2026
In 2026, OCULAR THERAPEUTIX, INC's disclosed short interest ran from 6.00% of shares outstanding on 15 Jan 2026 to 13.63% on 15 Sep 2026, a change of +7.63 percentage points. The year's high was 13.63% on 15 Sep 2026 and its low 5.40% on 30 Jan 2026, averaging 10.72% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.19 days on 15 Sep 2026. Full history: OCULAR THERAPEUTIX, INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 6.00% (15 Jan 2026)
- End of year
- 13.63% (15 Sep 2026)
- Change
- +7.63 pp
- High
- 13.63% (15 Sep 2026)
- Low
- 5.40% (30 Jan 2026)
- Average
- 10.72%
- Highest days to cover
- 14.19 (15 Sep 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 6.00% | 2.21 | |
| 30 Jan 2026 | 5.40% | 2.70 | |
| 13 Feb 2026 | 6.76% | 2.98 | 10-K filed, results (8-K) |
| 27 Feb 2026 | 8.11% | 1.44 | |
| 13 Mar 2026 | 10.88% | 3.56 | |
| 31 Mar 2026 | 11.57% | 7.20 | |
| 15 Apr 2026 | 11.27% | 6.99 | |
| 30 Apr 2026 | 11.39% | 8.57 | |
| 15 May 2026 | 11.32% | 8.49 | 10-Q filed, results (8-K) |
| 29 May 2026 | 11.46% | 9.04 | |
| 15 Jun 2026 | 12.08% | 11.85 | |
| 30 Jun 2026 | 12.19% | 6.56 | |
| 15 Jul 2026 | 12.34% | 13.07 | |
| 31 Jul 2026 | 12.17% | 13.49 | |
| 14 Aug 2026 | 12.98% | 12.68 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 12.77% | 8.96 | |
| 15 Sep 2026 | 13.63% | 14.19 |
See also: OCULAR THERAPEUTIX, INC's full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.